CJ Cheiljedang Corp. proved it has gained popularity in the United States after its latest sales report showed it went over the $73 million mark. This revenue indicated a three-fold increase since it acquired the major US food firm - Schwan's Company - in 2019.
The South Korean food manufacturer said on Monday, Oct. 30, that the collective sales of its frozen rice products which were locally produced and sold in the U.S. have gone beyond the KRW100 billion or $74 million level. The company now expects the numbers to reach more than KRW130 billion or $96 million by the end of this year.
CJ Cheiljedang’s Products in the U.S.
As per The Korea Economic Daily, CJ Cheiljedang’s acquisition of Schwan's Company four years ago greatly helped in its expansion in the country. Since the US-based firm is already an established business, the South Korean food company was able to immediately secure a cold chain distribution system across the nation.
CJ Cheiljedang’s flagship products such as Chicken with Korean BBQ Flavor, Kimchi, Soy Garlic Shrimp, fried rice, and others are now widely distributed there. These food items are being made at Schwan's Vermont manufacturing plant instead of being exported from South Korean plants. These are regularly distributed to major US retail outlets such as Target, Walmart, and Target.
The Popularity of Frozen Rice
CJ CheilJedang believes that the popularity of its frozen rice packages in the U.S. market was due to the adaptation of Korean food culture to suit the palate of the local customers, Korea Joongang Daily reported. The firm added that the most sought-after rice-based processed foods are the kimchi, garlic, and Korean barbecue flavors and these have the biggest sales in the range.
"We added flavors such as Korean BBQ sauce, kimchi, and garlic to the most popular fried rice flavors in the United States, including chicken, vegetables, and shrimp," the company explained.
Photo by: Kawin Harasai/Unsplash


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 



